AstraZeneca Pharma India Limited — Others, 06-11-2024: Certificate under SEBI (Depositories and Participants) Regulations, 2018

AstraZeneca Pharma India Limited has received a compliance certificate from Integrated Registry Management Services confirming adherence to SEBI regulations regarding dematerialization of securities for the period from October 1 to October 31, 2024. The certificate verifies that all necessary actions, including listing and cancellation of securities, have been completed within the stipulated timeframe.